Induction of monocyte-to-dendritic cell maturation by extracorporeal photochemotherapy: initiation via direct platelet signaling.

[1]  R. Tigelaar,et al.  Activation of GILZ gene by photoactivated 8-methoxypsoralen: potential role of immunoregulatory dendritic cells in extracorporeal photochemotherapy. , 2014, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[2]  K. Kakimi,et al.  [Dendritic cells for cancer immunotherapy]. , 2012, Nihon rinsho. Japanese journal of clinical medicine.

[3]  T. Kuzel,et al.  Long‐term follow‐up and survival of cutaneous T‐cell lymphoma patients treated with extracorporeal photopheresis , 2012, Photodermatology, photoimmunology & photomedicine.

[4]  C. Drake,et al.  Ipilimumab: An Anti-CTLA-4 Antibody for Metastatic Melanoma , 2011, Clinical Cancer Research.

[5]  Hongyu Zhao,et al.  Rapid generation of maturationally synchronized human dendritic cells: contribution to the clinical efficacy of extracorporeal photochemotherapy. , 2010, Blood.

[6]  P. Kantoff,et al.  Sipuleucel-T immunotherapy for castration-resistant prostate cancer. , 2010, The New England journal of medicine.

[7]  P. Grimbert,et al.  Extracorporeal photopheresis: from solid organs to face transplantation. , 2009, Transplant immunology.

[8]  Franco Patrone,et al.  The use of dendritic cells in cancer immunotherapy. , 2008, Critical reviews in oncology/hematology.

[9]  A. Balduzzi,et al.  Extracorporeal Photochemotherapy Is Accompanied by Increasing Levels of Circulating CD4+CD25+GITR+Foxp3+CD62L+ Functional Regulatory T-Cells in Patients With Graft-Versus-Host Disease , 2007, Transplantation.

[10]  M. Erturk,et al.  Active immunotherapy for cancer patients using tumor lysate pulsed dendritic cell vaccine: a safety study. , 2007, Journal of experimental & clinical cancer research : CR.

[11]  D. Hume,et al.  Gpnmb Is Induced in Macrophages by IFN-γ and Lipopolysaccharide and Acts as a Feedback Regulator of Proinflammatory Responses1 , 2007, The Journal of Immunology.

[12]  W. Thomas.  Understanding the Counterintuitive Phenomenon of Catch Bonds , 2007 .

[13]  E. Shpall,et al.  Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD. , 2006, Blood.

[14]  L. Wilson,et al.  Transimmunization for cutaneous T cell lymphoma: A phase I study , 2006, Leukemia & lymphoma.

[15]  Z. Trajanoski,et al.  Effector memory T cells, early metastasis, and survival in colorectal cancer. , 2005, The New England journal of medicine.

[16]  Yeong‐Min Park,et al.  The Synthetic Peptide Trp-Lys-Tyr-Met-Val-D-Met Inhibits Human Monocyte-Derived Dendritic Cell Maturation via Formyl Peptide Receptor and Formyl Peptide Receptor-Like 21 , 2005, The Journal of Immunology.

[17]  A. Palucka,et al.  Dendritic cells as therapeutic vaccines against cancer , 2005, Nature Reviews Immunology.

[18]  D. Ridgway.  The First 1000 Dendritic Cell Vaccinees , 2003, Cancer investigation.

[19]  G. Gorgun,et al.  Immunologic mechanisms of extracorporeal photochemotherapy in chronic graft-versus-host disease. , 2002, Blood.

[20]  Thilo Stehle,et al.  Crystal Structure of the Extracellular Segment of Integrin αVβ3 in Complex with an Arg-Gly-Asp Ligand , 2002, Science.

[21]  T. Springer,et al.  Selectin receptor-ligand bonds: Formation limited by shear rate and dissociation governed by the Bell model. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[22]  J. Hutchcroft,et al.  CD80 and CD86 Are Not Equivalent in Their Ability to Induce the Tyrosine Phosphorylation of CD28* , 1999, The Journal of Biological Chemistry.

[23]  H. Hönigsmann,et al.  Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease. , 1998, Blood.

[24]  J. Banchereau,et al.  A novel lysosome-associated membrane glycoprotein, DC-LAMP, induced upon DC maturation, is transiently expressed in MHC class II compartment. , 1998, Immunity.

[25]  P. Rubegni,et al.  Extracorporeal photochemotherapy restores Th1/Th2 imbalance in patients with early stage cutaneous T‐cell lymphoma , 1997, Immunology.

[26]  W. Macey,et al.  Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alfa: a 10-year experience at a single institution. , 1996, Journal of the American Academy of Dermatology.

[27]  A. Lanzavecchia,et al.  Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation , 1996, The Journal of experimental medicine.

[28]  E Ruoslahti,et al.  RGD and other recognition sequences for integrins. , 1996, Annual review of cell and developmental biology.

[29]  J. Weisel,et al.  Examination of the platelet membrane glycoprotein IIb-IIIa complex and its interaction with fibrinogen and other ligands by electron microscopy. , 1992, The Journal of biological chemistry.

[30]  L. Walsh,et al.  Extracorporeal Photochemotherapy Induces the Production of Tumor Necrosis Factor-α by Monocytes: Implications for the Treatment of Cutaneous T-Cell Lymphoma and Systemic Sclerosis , 1992 .

[31]  S. Malawista,et al.  Treatment of rheumatoid arthritis by extracorporeal photochemotherapy. A pilot study. , 1991, Arthritis and rheumatism.

[32]  K Wolff,et al.  Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results. , 1987, The New England journal of medicine.

[33]  M. Drillings,et al.  Platelet alpha-granule proteins: studies on release and subcellular localization. , 1979, Blood.